Skip to content
lifestyle.socialsinsider.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Insight Molecular Diagnostics Inc.
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference
May 20, 2026
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
May 19, 2026
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
May 14, 2026
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
March 3, 2026
iMDx Announces $26.0 Million Registered Direct Offering
February 12, 2026
←
Previous Page
1
2